Fuchs endothelial corneal dystrophy and corneal endothelial diseases: East meets West.
Journal
Eye (London, England)
ISSN: 1476-5454
Titre abrégé: Eye (Lond)
Pays: England
ID NLM: 8703986
Informations de publication
Date de publication:
03 2020
03 2020
Historique:
received:
05
09
2018
accepted:
27
04
2019
revised:
21
04
2019
pubmed:
4
7
2019
medline:
22
6
2021
entrez:
4
7
2019
Statut:
ppublish
Résumé
Fuchs endothelial corneal dystrophy (FECD) is amongst one of the most common indications for endothelial keratoplasty worldwide. Despite being originally described among Caucasians, it is now known to be prevalent among a large number of populations, including Asians. While the FECD phenotype is classically described as that of central guttate and pigment deposits associated with corneal endothelial dysfunction, there are subtle yet important differences in how FECD and its phenocopies may present in Caucasians vs Asians. Such differences are paralled by genotypic variations and disease management preferences which appear to be geographically and ethnically delineated. This article provides a succinct review of such differences, with a focus on diagnostic and management issues which may be encountered by ophthalmologists practicing in the different geographic regions, when evaluating a patient with FECD. 摘要: 在全球范围内, Fuchs角膜内皮营养不良 (FECD) 是角膜内皮移植术最常见的适应症之一。尽管FECD最早报道于高加索人, 但目前已在包括亚洲人在内的人群中广泛流行。 FECD的典型临床表现是与角膜内皮细胞营养不良相关的中心斑点和色素沉着, 然而FECD和其拟表型在高加索人种和亚洲人种中的表现可能有细微但重要的差别。这些差别与基因多态性及与疾病管理的首选方式随区域和种族的不同相关。本篇文章简短地回顾了这些差别, 重点强调当眼科医生在不同地区面对FECD患者时, 诊断与管理方面的问题。.
Autres résumés
Type: Publisher
(chi)
摘要: 在全球范围内, Fuchs角膜内皮营养不良 (FECD) 是角膜内皮移植术最常见的适应症之一。尽管FECD最早报道于高加索人, 但目前已在包括亚洲人在内的人群中广泛流行。 FECD的典型临床表现是与角膜内皮细胞营养不良相关的中心斑点和色素沉着, 然而FECD和其拟表型在高加索人种和亚洲人种中的表现可能有细微但重要的差别。这些差别与基因多态性及与疾病管理的首选方式随区域和种族的不同相关。本篇文章简短地回顾了这些差别, 重点强调当眼科医生在不同地区面对FECD患者时, 诊断与管理方面的问题。.
Identifiants
pubmed: 31267087
doi: 10.1038/s41433-019-0497-9
pii: 10.1038/s41433-019-0497-9
pmc: PMC7042366
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
427-441Références
Wilson SE, Bourne WM. ‘Fuchs’ dystrophy. Cornea. 1988;7:2–18.
pubmed: 3280235
Elhalis H, Azizi B, Jurkunas UV. Fuchs endothelial corneal dystrophy. Ocul Surf. 2010;8:173–84.
pubmed: 20964980
pmcid: 3061348
Soh YQ, Peh GS, Mehta JS. Evolving therapies for Fuchs’ endothelial dystrophy. Regen Med. 2018;13:97–115.
pubmed: 29360003
Bhogal M, Lwin CN, Seah X-Y, Peh G, Mehta JS. Allogeneic Descemet’s membrane transplantation enhances corneal endothelial monolayer formation and restores functional integrity following Descemet’s stripping. Invest Ophthalmol Vis Sci. 2017;58:4249–60.
pubmed: 28850636
Soh YQ, Mehta JS. Regenerative therapy for Fuchs endothelial corneal dystrophy. Cornea. 2018;37:523–7.
pubmed: 29384808
Kinoshita S, Koizumi N, Ueno M, Okumura N, Imai K, Tanaka H, et al. Injection of cultured cells with a ROCK inhibitor for bullous keratopathy. N Engl J Med. 2018;378:995–1003.
pubmed: 29539291
Jinek M, Chylinski K, Fonfara I, Hauer M, Doudna JA, Charpentier E. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science. 2012;337:816–21.
pubmed: 22745249
pmcid: 6286148
Cong L, Ran FA, Cox D, Lin S, Barretto R, Habib N, et al. Multiplex genome engineering using CRISPR/Cas systems. Science. 2013;339:819–23.
pubmed: 23287718
pmcid: 3795411
Zhu AY, Jaskula-Ranga V, Jun AS. Gene editing as a potential therapeutic solution for Fuchs endothelial corneal dystrophy: the future is clearer. JAMA Ophthalmol. 2018;136:969–70.
pubmed: 29931030
Williams KA, Irani YD. Gene therapy and gene editing for the corneal dystrophies. Asia-Pac J Ophthalmol Phila Pa. 2016;5:312–6.
Christie KA, Courtney DG, DeDionisio LA, Shern CC, De Majumdar S, Mairs LC, et al. Towards personalised allele-specific CRISPR gene editing to treat autosomal dominant disorders. Sci Rep. 2017;7:16174.
pubmed: 29170458
pmcid: 5701044
Zoega GM, Fujisawa A, Sasaki H, Kubota A, Sasaki K, Kitagawa K, et al. Prevalence and risk factors for cornea guttata in the Reykjavik Eye Study. Ophthalmology. 2006;113:565–9.
pubmed: 16581419
Eghrari AO, McGlumphy EJ, Iliff BW, Wang J, Emmert D, Riazuddin SA, et al. Prevalence and severity of Fuchs corneal dystrophy in Tangier Island. Am J Ophthalmol. 2012;153:1067–72.
pubmed: 22321803
pmcid: 4154491
Higa A, Sakai H, Sawaguchi S, Iwase A, Tomidokoro A, Amano S, et al. Prevalence of and risk factors for cornea guttata in a population-based study in a southwestern island of Japan: the Kumejima study. Arch Ophthalmol. 2011;129:332–6.
pubmed: 21402991
Kitagawa K, Kojima M, Sasaki H, Shui Y-B, Chew SJ, Cheng H-M, et al. Prevalence of primary cornea guttata and morphology of corneal endothelium in aging Japanese and Singaporean subjects. Ophthalmic Res. 2002;34:135–8.
pubmed: 12097795
Breu A, Sprinzing B, Merkl K, Bechmann V, Kujat R, Jenei-Lanzl Z, et al. Estrogen reduces cellular aging in human mesenchymal stem cells and chondrocytes. J Orthop Res Publ Orthop Res Soc. 2011;29:1563–71.
Imanishi T, Hano T, Nishio I. Estrogen reduces endothelial progenitor cell senescence through augmentation of telomerase activity. J Hypertens. 2005;23:1699–706.
pubmed: 16093915
Imanishi T, Kobayashi K, Hano T, Nishio I. Effect of estrogen on differentiation and senescence in endothelial progenitor cells derived from bone marrow in spontaneously hypertensive rats. Hypertens Res. 2005;28:763–72.
pubmed: 16419650
Imanishi T, Tsujioka H, Akasaka T. Endothelial progenitor cell senescence—is there a role for estrogen? Ther. Adv. Cardiovasc Dis. 2010;4:55–69.
Jurkunas UV, Bitar MS, Funaki T, Azizi B. Evidence of oxidative stress in the pathogenesis of fuchs endothelial corneal dystrophy. Am J Pathol. 2010;177:2278–89.
pubmed: 20847286
pmcid: 2966787
Katikireddy KR, White TL, Miyajima T, Vasanth S, Raoof D, Chen Y, et al. NQO1 downregulation potentiates menadione-induced endothelial-mesenchymal transition during rosette formation in Fuchs endothelial corneal dystrophy. Free Radic Biol Med. 2018;116:19–30.
pubmed: 29294389
Matthaei M, Zhu AY, Kallay L, Eberhart CG, Cursiefen C, Jun AS. Transcript profile of cellular senescence-related genes in Fuchs endothelial corneal dystrophy. Exp Eye Res. 2014;129:13–7.
pubmed: 25311168
pmcid: 4259834
Young AR. Acute effects of UVR on human eyes and skin. Prog Biophys Mol Biol. 2006;92:80–5.
pubmed: 16600340
Henriksen K, Stamnes K, Volden G, Falk ES. Ultraviolet radiation at high latitudes and the risk of skin cancer. Photodermatol. 1989;6:110–7.
pubmed: 2762201
Willmann G. Ultraviolet keratitis: from the pathophysiological basis to prevention and clinical management. High Alt Med Biol. 2015;16:277–82.
pubmed: 26680683
Kroesch P. Summer eye safety: too often, a glaring omission. Occup Health Saf (Waco Tex). 2015;84:14.
Boulos EN, Jack D, Surowiec R, Bomback JL, Subramanian S, Simmons CJ, et al. Fundamental issues in automotive veiling glare. Warrendale, PA: SAE Technical Paper; 1997. https://www.sae.org/publications/technical-papers/content/970227/ . Accessed 7 Aug 2018.
Bornman JF, Barnes PW, Robinson SA, Ballaré CL, Flint SD, Caldwell MM. Solar ultraviolet radiation and ozone depletion-driven climate change: effects on terrestrial ecosystems. Photochem Photobiol Sci. 2015;14:88–107.
pubmed: 25435216
Bais AF, McKenzie RL, Bernhard G, Aucamp PJ, Ilyas M, Madronich S, et al. Ozone depletion andclimate change: impacts on UV radiation. Photochem Photobiol Sci. 2015;14:19–52.
pubmed: 25380284
Doré J-F, Chignol M-C. UV driven tanning salons: danger on main street. Adv Exp Med Biol. 2017;996:335–46.
pubmed: 29124713
Savoye I, Cervenka I, Mahamat-Saleh Y, Boutron-Ruault M-C, Kvaskoff M. Factors associated with sunbed use in women: the E3N-SunExp Study. Am J Health Behav. 2018;42:85–98.
pubmed: 29320342
Arnold M, Kvaskoff M, Thuret A, Guénel P, Bray F, Soerjomataram I. Cutaneous melanoma in France in 2015 attributable to solar ultraviolet radiation and the use of sunbeds. J Eur Acad Dermatol Venereol Jeadv. 2018;32:1681–6.
pubmed: 29706005
Moan JE, Baturaite Z, Grigalavicius M, Juzeniene A. Sunbed use and cutaneous melanoma in Norway. Scand J Public Health. 2013;41:812–7.
pubmed: 23907734
Køster B, Thorgaard C, Philip A, Clemmensen H. Sunbed use and campaign initiatives in the Danish population, 2007–9: a cross-sectional study. J Eur Acad Dermatol Venereol Jeadv. 2011;25:1351–5.
pubmed: 21711466
Strachan IM, Maclean H. Posterior polymorphous dystrophy of the cornea. Br J Ophthalmol. 1968;52:270–2.
pubmed: 5300525
pmcid: 506568
Aldave AJ, Ann LB, Frausto RF, Nguyen CK, Yu F, Raber IM. Classification of posterior polymorphous corneal dystrophy as a corneal ectatic disorder following confirmation of associated significant corneal steepening. JAMA Ophthalmol. 2013;131:1583–90.
pubmed: 24113819
pmcid: 3888803
Aldave AJ, Yellore VS, Yu F, Bourla N, Sonmez B, Salem AK, et al. Posterior polymorphous corneal dystrophy is associated with TCF8 gene mutations and abdominal hernia. Am J Med Genet A. 2007;143A:2549–56.
pubmed: 17935237
Krafchak CM, Pawar H, Moroi SE, Sugar A, Lichter PR, Mackey DA, et al. Mutations in TCF8 cause posterior polymorphous corneal dystrophy and ectopic expression of COL4A3 by corneal endothelial cells. Am J Hum Genet. 2005;77:694–708.
pubmed: 16252232
pmcid: 1271382
Teekhasaenee C, Nimmanit S, Wutthiphan S, Vareesangthip K, Laohapand T, Malasitr P, et al. Posterior polymorphous dystrophy and Alport syndrome. Ophthalmology. 1991;98:1207–15.
pubmed: 1923357
Krachmer JH. Posterior polymorphous corneal dystrophy: a disease characterized by epithelial-like endothelial cells which influence management and prognosis. Trans Am Ophthalmol Soc. 1985;83:413–75.
pubmed: 3914130
pmcid: 1298709
Cibis GW, Krachmer JA, Phelps CD, Weingeist TA. The clinical spectrum of posterior polymorphous dystrophy. Arch Ophthalmol. 1977;95:1529–37.
pubmed: 302697
Héon E, Greenberg A, Kopp KK, Rootman D, Vincent AL, Billingsley G, et al. VSX1: a gene for posterior polymorphous dystrophy and keratoconus. Hum Mol Genet. 2002;11:1029–36.
pubmed: 11978762
Valleix S, Nedelec B, Rigaudiere F, Dighiero P, Pouliquen Y, Renard G, et al. H244R VSX1 is associated with selective cone ON bipolar cell dysfunction and macular degeneration in a PPCD family. Invest Ophthalmol Vis Sci. 2006;47:48–54.
pubmed: 16384943
Biswas S, Munier FL, Yardley J, Hart-Holden N, Perveen R, Cousin P, et al. Missense mutations in COL8A2, the gene encoding the alpha2 chain of type VIII collagen, cause two forms of corneal endothelial dystrophy. Hum Mol Genet. 2001;10:2415–23.
pubmed: 11689488
Vincent AL, Niederer RL, Richards A, Karolyi B, Patel DV, McGhee CNJ. Phenotypic characterisation and ZEB1 mutational analysis in posterior polymorphous corneal dystrophy in a New Zealand population. Mol Vis. 2009;15:2544–53.
pubmed: 19997581
pmcid: 2788618
Okumura N, Minamiyama R, Ho LT, Kay EP, Kawasaki S, Tourtas T, et al. Involvement of ZEB1 and Snail1 in excessive production of extracellular matrix in Fuchs endothelial corneal dystrophy. Lab Investig. 2015;95:1291–304.
pubmed: 26302187
Ang M, Sng CCA, Chee S-P, Tan DTH, Mehta JS. Outcomes of corneal transplantation for irreversible corneal decompensation secondary to corneal endotheliitis in Asian eyes. Am J Ophthalmol.2013;156:260–6.
pubmed: 23622566
Anshu A, Chee S-P, Mehta JS, Tan DTH. Cytomegalovirus endotheliitis in Descemet’s stripping endothelial keratoplasty. Ophthalmology. 2009;116:624–30.
pubmed: 19195708
Waduthantri S, Zhou L, Chee S-P. Intra-cameral level of ganciclovir gel, 0.15% following topical application for cytomegalovirus anterior segment infection: a pilot study. PloS ONE. 2018;13:e0191850.
pubmed: 29377953
pmcid: 5788360
Sánchez-Tilló E, de Barrios O, Siles L, Cuatrecasas M, Castells A, Postigo A. β-catenin/TCF4 complex induces the epithelial-to-mesenchymal transition (EMT)-activator ZEB1 to regulate tumor invasiveness. Proc Natl Acad Sci USA. 2011;108:19204–9.
pubmed: 22080605
Liskova P, Gwilliam R, Filipec M, Jirsova K, Reinstein Merjava S, Deloukas P, et al. High prevalence of posterior polymorphous corneal dystrophy in the Czech Republic; linkage disequilibrium mapping and dating an ancestral mutation. PLoS ONE. 2012;7:e45495. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3458081/ .
pubmed: 23049806
pmcid: 3458081
Pandrowala H, Bansal A, Vemuganti GK, Rao GN. Frequency, distribution, and outcome of keratoplasty for corneal dystrophies at a tertiary eye care center in South India. Cornea. 2004;23:541–6.
pubmed: 15256989
Rodriguez A, Calonge M, Pedroza-Seres M, Akova YA, Messmer EM, D’Amico DJ, et al. Referral patterns of uveitis in a tertiary eye care center. Arch Ophthalmol. 1996;114:593–9.
pubmed: 8619771
Touhami S, Qu L, Angii M, Bojanova M, Touitou V, Lehoang P, et al. Cytomegalovirus anterior uveitis: clinical characteristics and long-term outcomes in a French series. Am J Ophthalmol. 2018;194:134–42.
pubmed: 30055154
Chan NS-W, Chee S-P, Caspers L, Bodaghi B. Clinical features of CMV-associated anterior uveitis. Ocul Immunol Inflamm. 2018;26:107–15.
pubmed: 29172842
Shahrudin NA, Mohd Zahidin AZ, Md Noh UK, Wan Abdul Halim WH, Md Din N. CMV endotheliitis: a cause for recurrent failed corneal transplant. GMS Ophthalmol Cases. 2017;7:Doc31.
pubmed: 29326863
pmcid: 5745971
Chee S-P, Bacsal K, Jap A, Se-Thoe S-Y, Cheng CL, Tan BH. Clinical features of cytomegalovirus anterior uveitis in immunocompetent patients. Am J Ophthalmol. 2008;145:834–40.
pubmed: 18255045
van Boxtel LAA, van der Lelij A, van der Meer J, Los LI. Cytomegalovirus as a cause of anterior uveitis in immunocompetent patients. Ophthalmology. 2007;114:1358–62.
pubmed: 17296229
Choi JA, Kim KS, Jung Y, Park HYL, Park CK. Cytomegalovirus as a cause of hypertensive anterior uveitis in immunocompetent patients. J Ophthalmic Inflamm Infect. 2016;6:32.
pubmed: 27613273
pmcid: 5017963
Cannon MJ, Schmid DS, Hyde TB. Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection. Rev Med Virol. 2010;20:202–13.
pubmed: 20564615
Numazaki K, Fujikawa T, Chiba S. Relationship between seropositivity of husbands and primary cytomegalovirus infection during pregnancy. J Infect Chemother. 2000;6:104–6.
pubmed: 11810545
Dar L, Pati SK, Patro ARK, Deorari AK, Rai S, Kant S, et al. Congenital cytomegalovirus infection in a highly seropositive semi-urban population in India. Pediatr Infect Dis J. 2008;27:841–3.
pubmed: 18645544
Sharma A, Rasul ES, Hazarika NK. A serological study of cytomegalovirus infection in pregnant and non-pregnant women at Gauhati Medical College and Hospital. J Indian Med Assoc. 2007;105:322–3. 320
Sheevani null, Jindal N, Aggarwal A. A pilot seroepidemiological study of cytomegalovirus infection in women of child bearing age. Indian J Med Microbiol. 2005;23:34–6.
pubmed: 15928419
Staras SAS, Dollard SC, Radford KW, Flanders WD, Pass RF, Cannon MJ. Seroprevalence of cytomegalovirus infection in the United States, 1988-1994. Clin Infect Dis Publ Infect Dis Soc Am. 2006;43:1143–51.
Berry NJ, Burns DM, Wannamethee G, Grundy JE, Lui SF, Prentice HG, et al. Seroepidemiologic studies on the acquisition of antibodies to cytomegalovirus, herpes simplex virus, and human immunodeficiency virus among general hospital patients and those attending a clinic for sexually transmitted diseases. J Med Virol. 1988;24:385–93.
pubmed: 2835432
Liesegang TJ, Melton LJ, Daly PJ, Ilstrup DM. Epidemiology of ocular herpes simplex. Incidence in Rochester, Minn, 1950 through 1982. Arch Ophthalmol. 1989;107:1155–9.
pubmed: 2787981
Kobayashi A, Yokogawa H, Higashide T, Nitta K, Sugiyama K. Clinical significance of owl eye morphologic features by in vivo laser confocal microscopy in patients with cytomegalovirus corneal endotheliitis. Am J Ophthalmol. 2012;153:445–53.
pubmed: 22030352
De Groot-Mijnes JDF, Rothova A, Van Loon AM, Schuller M, Ten Dam-Van Loon NH, De Boer JH, et al. Polymerase chain reaction and Goldmann-Witmer coefficient analysis are complimentary for the diagnosis of infectious uveitis. Am J Ophthalmol. 2006;141:313–8.
pubmed: 16458686
Faith SC, Durrani AF, Jhanji V. Cytomegalovirus keratitis. Curr Opin Ophthalmol. 2018;29:373–7.
pubmed: 29708927
Hsiao C-H, Hwang Y-S, Chuang W-Y, Ma DHK, Yeh L-K, Chen S-Y, et al. Prevalence and clinical consequences of cytomegalovirus DNA in the aqueous humour and corneal transplants. Br J Ophthalmol. 2019;103:666–71.
Anshu A, Tan D, Chee S-P, Mehta JS, Htoon HM. Interventions for the management of CMV-associated anterior segment inflammation. Cochrane Database Syst Rev. 2017;8:CD011908.
pubmed: 28838031
Koizumi N, Inatomi T, Suzuki T, Shiraishi A, Ohashi Y, Kandori M, et al. Clinical features and management of cytomegalovirus corneal endotheliitis: analysis of 106 cases from the Japan corneal endotheliitis study. Br J Ophthalmol. 2015;99:54–8.
pubmed: 25075122
Niyadurupola N, Broadway DC. Pigment dispersion syndrome and pigmentary glaucoma—a major review. Clin Exp Ophthalmol. 2008;36:868–82.
pubmed: 19278484
Siddiqui Y, Ten Hulzen RD, Cameron JD, Hodge DO, Johnson DH. What is the risk of developing pigmentary glaucoma from pigment dispersion syndrome? Am J Ophthalmol. 2003;135:794–9.
pubmed: 12788118
Evans W, Odom R, Wenaas E. Krukenberg’s spindle A study of 202 collected cases. Arch Ophthalmol. 2018;26:1023–56.
Qing G, Wang N, Tang X, Zhang S, Chen H. Clinical characteristics of pigment dispersion syndrome in Chinese patients. Eye Lond Engl. 2009;23:1641–6.
Walkden A, Au L. Iridocorneal endothelial syndrome: clinical perspectives. Clin Ophthalmol Auckl Nz. 2018;12:657–64.
Wilson MC, Shields MB. A comparison of the clinical variations of the iridocorneal endothelial syndrome. Arch Ophthalmol. 1989;107:1465–8.
pubmed: 2803093
Teekhasaenee C, Ritch R. Iridocorneal endothelial syndrome in Thai patients: clinical variations. Arch Ophthalmol. 2000;118:187–92.
pubmed: 10676783
Chandran P, Rao HL, Mandal AK, Choudhari NS, Garudadri CS, Senthil S. Glaucoma associated with iridocorneal endothelial syndrome in 203 Indian subjects. PLoS ONE. 2017;12:e0171884. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5345787/ .
pubmed: 28282413
pmcid: 5345787
Malhotra C, Pandav SS, Gupta A, Jain AK. Phenotypic heterogeneity of corneal endothelium in iridocorneal endothelial syndrome by in vivo confocal microscopy. Cornea. 2014;33:634–7.
pubmed: 24727634
Gupta V, Kumar R, Gupta R, Srinivasan G, Sihota R. Bilateral iridocorneal endothelial syndrome in a young girl with Down’s syndrome. Indian J Ophthalmol. 2009;57:61–3.
pubmed: 19075416
pmcid: 2661535
Islam F, Azad N, Khan A. Bilateral iridocorneal endothelial (ICE) syndrome with microspherophakia. J Coll Physicians Surg –Pak Jcpsp. 2011;21:374–5.
pubmed: 21711999
Huna R, Barak A, Melamed S. Bilateral iridocorneal endothelial syndrome presented as Cogan-Reese and Chandler’s syndrome. J Glaucoma. 1996;5:60–2.
pubmed: 8795735
Zhao H, Tang X. Analysis of the misdiagnosis of bilateral iridocorneal endothelial syndrome. Zhonghua Yi Xue Za Zhi. 2012;92:1317–20.
pubmed: 22883118
Sacchetti M, Mantelli F, Marenco M, Macchi I, Ambrosio O, Rama P. Diagnosis and management of iridocorneal endothelial syndrome. BioMed Res Int.2015;2015:763093
pubmed: 26451377
pmcid: 4588350
Azari AA, Rezaei Kanavi M, Thompson MJ, Altaweel MM, Potter HD, Albert DM. Iridocorneal endothelial syndrome. JAMA Ophthalmol. 2014;132:56.
pubmed: 24407828
Siak J, Chee S-P. Cytomegalovirus anterior uveitis following topical cyclosporine A. Ocul Immunol Inflamm. 2018;26:90–3.
pubmed: 28448732
Babu K, Murthy GJ. Cytomegalovirus anterior uveitis in immunocompetent individuals following topical prostaglandin analogues. J Ophthalmic Inflamm Infect. 2013;3:55.
pubmed: 23837444
pmcid: 3721988
Sims JL, Chee SP. Cytomegalovirus endotheliitis following fluocinolone acetonide (Retisert) implant. Eye Lond Engl. 2010;24:197–8.
Yang Y, Teja S, Baig K. Bilateral corneal edema associated with amantadine. CMAJ Can Med Assoc J. 2015;187:1155–8.
Chang KC, Jeong JH, Kim MK, Wee WR, Lee JH, Jeon BS. The effect of amantadine on corneal endothelium in subjects with Parkinson’s disease. Ophthalmology. 2010;117:1214–9.
pubmed: 20153901
Sundin OH, Jun AS, Broman KW, Liu SH, Sheehan SE, Vito ECL, et al. Linkage of late-onset Fuchs corneal dystrophy to a novel locus at 13pTel-13q12.13. Investig Opthalmology Vis Sci. 2006;47:140.
Sundin OH, Broman KW, Chang HH, Vito ECL, Stark WJ, Gottsch JD. A common locus for late-onset Fuchs corneal dystrophy maps to 18q21.2-q21.32. Investig Opthalmology Vis Sci. 2006;47:3919.
Riazuddin SA, Eghrari AO, Al-Saif A, Davey L, Meadows DN, Katsanis N, et al. Linkage of a Mild Late-onset Phenotype of Fuchs Corneal Dystrophy To A Novel Locus at 5q33.1-q35.2. Investig Opthalmology Vis Sci. 2009;50:5667.
Riazuddin SA, Zaghloul NA, Al-Saif A, Davey L, Diplas BH, Meadows DN, et al. Missense mutations in TCF8 cause late-onset Fuchs corneal dystrophy and interact with FCD4 on chromosome 9p. Am J Hum Genet. 2010;86:45–53.
pubmed: 20036349
pmcid: 2801746
Vithana EN, Morgan P, Sundaresan P, Ebenezer ND, Tan DTH, Mohamed MD, et al. Mutations in sodium-borate cotransporter SLC4A11 cause recessive congenital hereditary endothelial dystrophy (CHED2). Nat Genet. 2006;38:755–7.
pubmed: 16767101
Rao BS, Ansar S, Arokiasamy T, Sudhir RR, Umashankar V, Rajagopal R, et al. Analysis of candidate genes ZEB1 and LOXHD1 in late-onset Fuchs’ endothelial corneal dystrophy in an Indian cohort. Ophthalmic Genet. 2018;39:443–9.
pubmed: 29799290
Afshari NA, Igo RP, Morris NJ, Stambolian D, Sharma S, Pulagam VL, et al. Genome-wide association study identifies three novel loci in Fuchs endothelial corneal dystrophy. Nat Commun. 2017;8:14898.
pubmed: 28358029
pmcid: 5379100
Liskova P, Prescott Q, Bhattacharya SS, Tuft SJ. British family with early‐onset Fuchs’ endothelial corneal dystrophy associated with p.L450W mutation in the COL8A2 gene. Br J Ophthalmol. 2007;91:1717–8.
pubmed: 18024822
pmcid: 2095500
Wieben ED, Aleff RA, Eckloff BW, Atkinson EJ, Baheti S, Middha S, et al. Comprehensive Assessment Of Genetic Variants Within TCF4 in Fuchs’ endothelial corneal dystrophy. Investig Opthalmology Vis Sci. 2014;55:6101.
Wieben ED, Aleff RA, Tang X, Butz ML, Kalari KR, Highsmith EW, et al. Trinucleotide repeat expansion in the transcription factor 4 (TCF4) gene leads to widespread mRNA splicing changes in Fuchs’ endothelial corneal dystrophy. Invest Ophthalmol Vis Sci. 2017;58:343–52.
pubmed: 28118661
pmcid: 5270622
Vithana EN, Morgan PE, Ramprasad V, Tan DTH, Yong VHK, Venkataraman D, et al. SLC4A11 mutations in Fuchs endothelial corneal dystrophy. Hum Mol Genet. 2008;17:656–66.
pubmed: 18024964
Xing C, Gong X, Hussain I, Khor C-C, Tan DTH, Aung T, et al. Transethnic replication of association of CTG18.1 repeat expansion of TCF4 gene with Fuchs’ corneal dystrophy in Chinese implies common causal variant. Invest Ophthalmol Vis Sci. 2014;55:7073–8.
pubmed: 25298419
pmcid: 4224583
Nakano M, Okumura N, Nakagawa H, Koizumi N, Ikeda Y, Ueno M, et al. Trinucleotide repeat expansion in the TCF4 gene in Fuchs’ endothelial corneal dystrophy in Japanese. Invest Ophthalmol Vis Sci. 2015;56:4865–9.
pubmed: 26218914
Rao BS, Tharigopala A, Rachapalli SR, Rajagopal R, Soumittra N. Association of polymorphisms in the intron of TCF4 gene to late-onset Fuchs endothelial corneal dystrophy: an Indian cohort study. Indian J Ophthalmol. 2017;65:931–5.
pubmed: 29044056
pmcid: 5678327
Nanda GG, Padhy B, Samal S, Das S, Alone DP. Genetic association of TCF4 intronic polymorphisms, CTG18.1 andrs17089887, with Fuchs’ endothelial corneal dystrophy in an Indian population. Invest Ophthalmol Vis Sci. 2014;55:7674–80.
pubmed: 25342617
Soliman AZ, Xing C, Radwan SH, Gong X, Mootha VV. Correlation of severity of Fuchs endothelial corneal dystrophy with triplet repeat expansion in TCF4. JAMA Ophthalmol. 2015;133:1386–91.
pubmed: 26401622
Vasanth S, Eghrari AO, Gapsis BC, Wang J, Haller NF, Stark WJ, et al. Expansion of CTG18.1 trinucleotide repeat in TCF4 is a potent driver of Fuchs’ corneal dystrophy. Invest Ophthalmol Vis Sci. 2015;56:4531–6.
pubmed: 26200491
pmcid: 4515948
Mootha VV, Gong X, Ku H-C, Xing C. Association and familial segregation of CTG18.1 trinucleotide repeat expansion of TCF4 gene in ‘Fuchs’ endothelial corneal dystrophy. Invest Ophthalmol Vis Sci. 2014;55:33–42.
pubmed: 24255041
pmcid: 3880006
Kuot A, Hewitt AW, Snibson GR, Souzeau E, Mills R, Craig JE, et al. TGC repeat expansion in the TCF4 gene increases the risk of ‘Fuchs’ endothelial corneal dystrophy in Australian cases. PLoS ONE. 2017;12. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5568371/ .
Luther M, Grünauer-Kloevekorn C, Weidle E, Passarge E, Rupprecht A, Hoffmann K, et al. TGC repeats in intron 2 of the TCF4 gene have a good predictive power regarding to Fuchs endothelial corneal dystrophy. Klin Monätter Für Augenheilkd. 2016;233:187–94.
Qin B, Tang M, Li Y, Zhang X, Chu R, Huang D. Anterior segment dimensions in Asian and Caucasian eyes measured by optical coherence tomography. Ophthalmic Surg. Lasers Imaging. 2012;43:135–42.
pubmed: 22320411
pmcid: 3402168
Cheng J-W, Zong Y, Zeng Y-Y, Wei R-L. The prevalence of primary angle closure glaucoma in adult Asians: a systematic review and meta-analysis. PLoS ONE. 2014;9. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4110010/ .
Wang PX, Koh VTC, Loon SC. Laser iridotomy and the corneal endothelium: a systemic review. Acta Ophthalmol (Copenh). 2014;92:604–16.
Kumar RS, Baskaran M, Friedman DS, Xu Y, Wong H-T, Lavanya R, et al. Effect of prophylactic laser iridotomy on corneal endothelial cell density over 3 years in primary angle closure suspects. Br J Ophthalmol. 2013;97:258–61.
pubmed: 23203700
Ang LPK, Higashihara H, Sotozono C, Shanmuganathan VA, Dua H, Tan DTH, et al. Argon laser iridotomy-induced bullous keratopathy a growing problem in Japan. Br J Ophthalmol. 2007;91:1613–5.
pubmed: 17567658
pmcid: 2095521
Ang M, Lim F, Htoon HM, Tan D, Mehta JS. Visual acuity and contrast sensitivity following Descemet stripping automated endothelial keratoplasty. Br J Ophthalmol. 2016;100:307–11.
pubmed: 26159453
Hamzaoglu EC, Straiko MD, Mayko ZM, Sáles CS, Terry MA. The first 100 eyes of standardized descemet stripping automated endothelial keratoplasty versus standardized descemet membrane endothelial keratoplasty. Ophthalmology. 2015;122:2193–9.
pubmed: 26271841
Nanavaty MA, Wang X, Shortt AJ. Endothelial keratoplasty versus penetrating keratoplasty for Fuchs endothelial dystrophy. Cochrane Database Syst Rev. 2014;CD008420.
Ang M, Soh Y, Htoon HM, Mehta JS, Tan D. Five-year graft survival comparing descemet stripping automated endothelial keratoplasty and penetrating keratoplasty. Ophthalmology. 2016;123:1646–52.
pubmed: 27262764
Kim SE, Lim SA, Byun Y-S, Joo C-K. Comparison of long-term clinical outcomes between Descemet’s stripping automated endothelial keratoplasty and penetrating keratoplasty in patients with bullous keratopathy. Korean J Ophthalmol. 2016;30:443–50.
pubmed: 27980363
pmcid: 5156618
Price MO, Gorovoy M, Price FW, Benetz BA, Menegay HJ, Lass JH. Descemet’s stripping automated endothelial keratoplasty: three-year graft and endothelial cell survival compared with penetrating keratoplasty. Ophthalmology. 2013;120:246–51.
pubmed: 23107581
Kobashi H, Kamiya K, Shimizu K. Factors influencing visual acuity in Fuchs’ endothelial corneal dystrophy. Optom Vis Sci Publ Am Acad Optom. 2018;95:21–6.
Wacker K, McLaren JW, Amin SR, Baratz KH, Patel SV. Corneal high-order aberrations and backscatter in Fuchs’ endothelial corneal dystrophy. Ophthalmology. 2015;122:1645–52.
pubmed: 26050543
pmcid: 4516693
Watanabe S, Oie Y, Fujimoto H, Soma T, Koh S, Tsujikawa M, et al. Relationship between corneal guttae and quality of vision in patients with mild Fuchs’ endothelial corneal dystrophy. Ophthalmology. 2015;122:2103–9.
pubmed: 26189189
Ple-Plakon PA, Shtein RM. Trends in corneal transplantation: indications and techniques. Curr Opin Ophthalmol. 2014;25:300–5.
pubmed: 24865170
Röck T, Bartz-Schmidt KU, Röck D. Trends in corneal transplantation at the University Eye Hospital in Tübingen, Germany over the last 12 years: 2004–2015. PloS ONE. 2018;13:e0198793.
pubmed: 29939996
pmcid: 6016935
Mathews PM, Lindsley K, Aldave AJ, Akpek EK. Etiology of global corneal blindness and current practices of corneal transplantation: a focused review. Cornea. 2018;37:1198–203.
pubmed: 29912039
Bigan G, Puyraveau M, Saleh M, Gain P, Martinache I, Delbosc B, et al. Corneal transplantation trends in France from 2004 to 2015: a 12-year review. Eur J Ophthalmol. 2018;28:535–40. 1120672118762224
pubmed: 29649920
Kim BZ, Meyer JJ, Brookes NH, Moffatt SL, Twohill HC, Pendergrast DG, et al. New Zealand trends in corneal transplantation over the 25 years 1991–2015. Br J Ophthalmol. 2017;101:834–8.
pubmed: 27635063
Tan JCH, Holland SP, Dubord PJ, Moloney G, McCarthy M, Yeung SN. Evolving indications for and trends in keratoplasty in British Columbia, Canada, from 2002 to 2011: a 10-year review. Cornea. 2014;33:252–6.
pubmed: 24457452
Coster DJ, Lowe MT, Keane MC, Williams KA. Australian corneal graft registry contributors. A comparison of lamellar and penetrating keratoplasty outcomes: a registry study. Ophthalmology. 2014;121:979–87.
pubmed: 24491643
Hong J, Shi W, Liu Z, Pineda R, Cui X, Sun X, et al. Limitations of keratoplasty in China: a survey analysis. PLoS ONE. 2015;10:e0132268. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4498799/ . Accessed 11 Aug 2018.
pubmed: 26161870
pmcid: 4498799
Dong PN, Han TN, Aldave AJ, Chau HTM. Indications for and techniques of keratoplasty at Vietnam National Institute of Ophthalmology. Int J Ophthalmol. 2016;9:379–83.
pubmed: 27158606
pmcid: 4844031
Rezaei Kanavi M, Javadi MA, Motevasseli T, Chamani T, Rezaei Kanavi M, Kheiri B, et al. Trends in Indications and techniques of corneal transplantation in Iran from 2006 to 2013; an 8-year review. J Ophthalmic Vis Res. 2016;11:146–52.
pubmed: 27413493
pmcid: 4926560
Crawford AZ, McKelvie J, Craig JP, McGhee CNJ, Patel DV. Corneal transplantation in Auckland, New Zealand, 1999-2009: indications, patient characteristics, ethnicity, social deprivation, and access to services. Cornea. 2017;36:546–52.
pubmed: 28257380
Edwards M, Clover GM, Brookes N, Pendergrast D, Chaulk J, McGhee CNJ. Indications for corneal transplantation in New Zealand: 1991–1999. Cornea. 2002;21:152–5.
pubmed: 11862084
Lee JS, Park YG, Yoon KC. Long-term results of Descemet’s stripping automated endothelial keratoplasty in Korea. J Korean Ophthalmol Soc. 2010;51:1431–7.
Kang DJ, Kim HK. Clinical outcomes of combined descemet-stripping endothelial keratoplasty and intraocular lens exchange. J Korean Ophthalmol Soc. 2016;57:1361–8.
Han GL, Hyun J, Lim DH, Chung ES, Chung TY. Clinical outcomes of Descemet’s membrane endothelial keratoplasty: a 1-year retrospective study. J Korean Ophthalmol Soc. 2015;56:1489–96.
Baek JW, Hwang KY, Joo C-K. Comparing clinical outcomes of Descemet’s membrane stripping automated endothelial keratoplasty between graft insertion methods. J Korean Ophthalmol Soc. 2013;54:1655–62.
Choi SH, Lee YW, Kim HM, Yang SM, Hong JU, Yoon KC, et al. Epidemiologic studies of keratoplasty in Korea. J Korean Ophthalmol Soc. 2006;47:538–47.
Shimazaki J, Amano S, Uno T, Maeda N, Yokoi N. National survey on bullous keratopathy in Japan. Cornea. 2007;26:274–8. Japan Bullous Keratopathy Study Group
pubmed: 17413952
Nishino T, Kobayashi A, Yokogawa H, Mori N, Masaki T, Sugiyama K. A 10-year review of underlying diseases for endothelial keratoplasty (DSAEK/DMEK) in a tertiary referral hospital in Japan. Clin Ophthalmol Auckl Nz. 2018;12:1359–65.
Eye Bank Association of America. Eye banking statistical report; 2016:1–99.
Lichtinger A, Yeung SN, Kim P, Amiran MD, Rootman DS. The era of lamellar keratoplasty, evolving surgical techniques in corneal transplantation: the University of Toronto experience. Can J Ophthalmol J Can Ophtalmol. 2012;47:287–90.
Frigo AC, Fasolo A, Capuzzo C, Fornea M, Bellucci R, Busin M, et al. Corneal transplantation activity over 7 years: changing trends for indications, patient demographics and surgical techniques from the Corneal Transplant Epidemiological Study (CORTES). Transplant Proc. 2015;47:528–35.
pubmed: 25769602
Ting DSJ, Sau CY, Srinivasan S, Ramaesh K, Mantry S, Roberts F. Changing trends in keratoplasty in the West of Scotland: a 10-year review. Br J Ophthalmol. 2012;96:405–8.
pubmed: 21733923
Flockerzi E, Maier P, Böhringer D, Reinshagen H, Kruse F, Cursiefen C, et al. Trends in corneal transplantation from 2001 to 2016 in Germany: a report of the DOG–section cornea and its keratoplasty registry. Am J Ophthalmol. 2018;188:91–8.
pubmed: 29410297
Tan DTH, Anshu A, Mehta JS. Paradigm shifts in corneal transplantation. Ann Acad Med Singap. 2009;38:332–8.
pubmed: 19434336
Aditya P. Evolving indications and trends in keratoplasty in Eastern India: a 5-year review. In: 75th Annual Conference of All India Ophthalmological Society (AIOS). Jaipuir, India; 2017. https://proceedings.aios.org/2017/fp1159-evolving-indications-and-trends-in-keratoplasty-in-eastern-india-a-5-year-review/ .
Mohamed A, Chaurasia S, Murthy SI, Ramappa M, Vaddavalli PK, Taneja M, et al. Endothelial keratoplasty: a review of indications at a tertiary eye care centre in South India. Asia-Pac J Ophthalmol Phila Pa. 2014;3:207–10.
Price MO, Giebel AW, Fairchild KM, Price FW. Descemet’s membrane endothelial keratoplasty: prospective multicenter study of visual and refractive outcomes and endothelial survival. Ophthalmology. 2009;116:2361–8.
pubmed: 19875170
Stuart AJ, Romano V, Virgili G, Shortt AJ. Descemet’s membrane endothelial keratoplasty (DMEK) versus Descemet’s stripping automated endothelial keratoplasty (DSAEK) for corneal endothelial failure. Cochrane Database Syst Rev. 2018;6:CD012097.
pubmed: 29940078
Zhu L, Zha Y, Cai J, Zhang Y. Descemet stripping automated endothelial keratoplasty versus descemet membrane endothelial keratoplasty: a meta-analysis. Int Ophthalmol. 2018;38:897–905.
pubmed: 28417337
Marques RE, Guerra PS, Sousa DC, Gonçalves AI, Quintas AM, Rodrigues W. DMEK versus DSAEK for Fuchs’ endothelial dystrophy: a meta-analysis. Eur J Ophthalmol. 2018;29:15–22.
pubmed: 29661044
Ang M, Mehta JS, Newman SD, Han SB, Chai J, Tan D. Descemet membrane endothelial keratoplasty: preliminary results of a donor insertion pull-through technique using a donor mat device. Am J Ophthalmol. 2016;171:27–34.
pubmed: 27565226
Gerber-Hollbach N, Parker J, Baydoun L, Liarakos VS, Ham L, Dapena I, et al. Preliminary outcome of hemi-Descemet membrane endothelial keratoplasty for Fuchs endothelial dystrophy. Br J Ophthalmol. 2016;100:1564–8.
pubmed: 26837507
Baydoun L, Zygoura V, Hsien S, Birbal RS, Spinozzi D, Lie JT, et al. Clinical feasibility of using multiple grafts from a single donor for Quarter-DMEK. Acta Ophthalmol (Copenh). 2018;96:e656–8.
Schlögl A, Tourtas T, Kruse FE, Weller JM. Long-term Clinical outcome after Descemet membrane endothelial keratoplasty. Am J Ophthalmol. 2016;169:218–26.
pubmed: 27423793
Fuest M, Ang M, Htoon HM, Tan D, Mehta JS. Long-term visual outcomes comparing Descemet stripping automated endothelial keratoplasty and penetrating keratoplasty. Am J Ophthalmol. 2017;182:62–71.
pubmed: 28739420
Yang M, Mehta JS, Tan DTH. Superficial keratectomy as a prelude for endothelial keratoplasty in severe bullous keratopathy with anterior stromal scarring. Cornea. 2010;29:108–9.
pubmed: 19907302
Peraza-Nieves J, Baydoun L, Dapena I, Ilyas A, Frank LE, Luceri S, et al. Two-year clinical outcome of 500 consecutive cases undergoing Descemet membrane endothelial keratoplasty. Cornea. 2017;36:655–60.
pubmed: 28410548
Soh YQ, Peh G, George BL, Seah XY, Primalani NK, Adnan K, et al. Predicative factors for corneal endothelial cell migration. Investig Opthalmology Vis Sci. 2016;57:338.
Kaufman AR, Nosé RM, Pineda R. Descemetorhexis without endothelial keratoplasty (DWEK): proposal for nomenclature standardization. Cornea. 2018;37:e20–1.
pubmed: 29384812
Soh YQ, Mehta JS. Selective endothelial removal for peters anomaly. Cornea. 2018;37:382–5.
pubmed: 29408830
Garnock-Jones KP. Ripasudil: first global approval. Drugs. 2014;74:2211–5.
pubmed: 25414122
Peh GSL, Adnan K, George BL, Ang H-P, Seah X-Y, Tan DT, et al. The effects of Rho-associated kinase inhibitor Y-27632 on primary human corneal endothelial cells propagated using a dual media approach. Sci Rep. 2015;5:9167.
pubmed: 25823914
pmcid: 4387913
Meekins LC, Rosado-Adames N, Maddala R, Zhao JJ, Rao PV, Afshari NA. Corneal endothelial cell migration and proliferation enhanced by rho kinase (ROCK) inhibitors in in vitro and in vivo models. Invest Ophthalmol Vis Sci. 2016;57:6731–8.
pubmed: 27951595
pmcid: 6018452
Okumura N, Matsumoto D, Fukui Y, Teramoto M, Imai H, Kurosawa T, et al. Feasibility of cell-based therapy combined with descemetorhexis for treating Fuchs endothelial corneal dystrophy in rabbit model. PloS ONE. 2018;13:e0191306.
pubmed: 29338061
pmcid: 5770073
Hu J, Rong Z, Gong X, Zhou Z, Sharma VK, Xing C, et al. Oligonucleotides targeting TCF4 triplet repeat expansion inhibit RNA foci and mis-splicing in Fuchs’ dystrophy. Hum Mol Genet. 2018;27:1015–26.
pubmed: 29325021
pmcid: 5886168
Mali P, Yang L, Esvelt KM, Aach J, Guell M, DiCarlo JE, et al. RNA-Guided Human Genome Engineering via Cas9. Science. 2013;339:823–6.
pubmed: 23287722
pmcid: 3712628
Hsu PD, Scott DA, Weinstein JA, Ran FA, Konermann S, Agarwala V, et al. DNA targeting specificity of RNA-guided Cas9 nucleases. Nat Biotechnol. 2013;31:827–32.
pubmed: 23873081
pmcid: 3969858
Hsu PD, Lander ES, Zhang F. Development and applications of CRISPR-Cas9 for genome engineering. Cell. 2014;157:1262–78.
pubmed: 24906146
pmcid: 4343198
Gaudelli NM, Komor AC, Rees HA, Packer MS, Badran AH, Bryson DI, et al. Programmable base editing of A•T to G•C in genomic DNA without DNA cleavage. Nature. 2017;551:464–71.
pubmed: 29160308
pmcid: 5726555
Abudayyeh OO, Gootenberg JS, Essletzbichler P, Han S, Joung J, Belanto JJ, et al. RNA targeting with CRISPR–Cas13. Nature. 2017;550:280–4.
pubmed: 28976959
pmcid: 5706658
Cox DBT, Gootenberg JS, Abudayyeh OO, Franklin B, Kellner MJ, Joung J, et al. RNA editing with CRISPR-Cas13. Science. 2017;358:1019–27.
pubmed: 29070703
pmcid: 5793859
Goar EL. Dystrophy of the corneal endothelium (cornea guttata), with report of a histologic examination. Trans Am Ophthalmol Soc. 1933;31:48–59.
pubmed: 16692989
pmcid: 1315418
Lorenzetti DW, Uotila MH, Parikh N, Kaufman HE. Central cornea guttata. Incidence in the general population. Am J Ophthalmol. 1967;64:1155–8.
pubmed: 6072991
Nagaki Y, Hayasaka S, Kitagawa K, Yamamoto S. Primary cornea guttata in Japanese patients with cataract: specular microscopic observations. Jpn J Ophthalmol. 1996;40:520–5.
pubmed: 9130056